Clinical trial

Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease

NCT00285077

Study summary

ClinicalTrials.gov

Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention SR57667B Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-03-01

PhasePHASE2

Conditions

Alzheimer Diseaseverified · MONDO: Alzheimer disease

Interventions

SR57667BDRUG

Sponsors & collaborators

Sanofilead sponsor

Mapped research locations

ParisFrance1 BerlinGermany1 HelsinkiFinland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00285077 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.